Comparative Expression Analyses of Pro- versus Anti-Inflammatory Mediators within Synovium of Patients with Joint Trauma, Osteoarthritis, and Rheumatoid Arthritis.

Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1466-1861 (Electronic) Linking ISSN: 09629351 NLM ISO Abbreviation: Mediators Inflamm Subsets: MEDLINE

Publication: 2023- : Hoboken, NJ : Wiley
Original Publication: Oxford, UK : Rapid Communications of Oxford Ltd., c1992-

Arthritis, Rheumatoid/*metabolism ; Osteoarthritis/*metabolism ; Synovial Membrane/*metabolism ; Wounds and Injuries/*metabolism; Aged ; Aged, 80 and over ; Arachidonate 5-Lipoxygenase/genetics ; Arthritis, Rheumatoid/immunology ; Female ; Fluorescent Antibody Technique ; Humans ; Interleukin-10/genetics ; Interleukin-1beta/genetics ; Male ; Middle Aged ; Osteoarthritis/immunology ; RNA, Messenger/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Synovial Membrane/immunology ; Tumor Necrosis Factor-alpha/genetics ; Wounds and Injuries/immunology

Synovial injury and healing are complex processes including catabolic effects by proinflammatory cytokines and anabolic processes by anti-inflammatory mediators. Here we examined the expression of pro- versus anti-inflammatory mediators in synovium of patients with diagnostic arthroscopy (control), joint trauma (JT), osteoarthritis (OA), and rheumatoid arthritis (RA). Synovial samples from these patients were subjected to RT-PCR and double immunofluorescence confocal microscopy of pro- and anti-inflammatory mediators as well as immune cell markers. Interestingly, pro- and anti-inflammatory mediators were expressed predominantly in granulocytes in patients with JT and in macrophages, lymphocytes, and plasma cells in patients with OA and RA. Interestingly, parallel to the severity of inflammation, proinflammatory mediators IL-1 β , TNF- α , and 5-LOX specific mRNA as well as immunoreactive (IR) cells were significantly more abundant in patients with RA and JT than in those with OA. However, anti-inflammatory mediators 15-LOX, FPR2, and IL-10 specific mRNA as well as IR cells were significantly more abundant in patients with OA than in those with JT and RA. These findings show that upregulation of proinflammatory mediators contributes to the predominantly catabolic inflammatory process in JT and RA synovium, whereas upregulation of anabolic anti-inflammatory mediators counteracts inflammation resulting in the inferior inflammatory process in OA synovium.
Competing Interests: The authors declare no conflict of interests.

J Immunol. 2010 Mar 1;184(5):2611-9. (PMID: 20107188)
Bull NYU Hosp Jt Dis. 2007;65 Suppl 1:S4-10. (PMID: 17708744)
Ann Rheum Dis. 2007 Jul;66(7):871-9. (PMID: 17324971)
FASEB J. 2000 Oct;14(13):2097-107. (PMID: 11023994)
J Interferon Cytokine Res. 1999 Jun;19(6):563-73. (PMID: 10433356)
Annu Rev Immunol. 2001;19:683-765. (PMID: 11244051)
Springer Semin Immunopathol. 1998;20(1-2):149-64. (PMID: 9836374)
Neuropharmacology. 2016 Aug;107:251-61. (PMID: 27016023)
BMC Complement Altern Med. 2015 Jan 24;15:1. (PMID: 25617057)
Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8686-91. (PMID: 15937121)
Arthritis Rheum. 1986 Aug;29(8):1039-49. (PMID: 3741515)
J Exp Med. 1994 May 1;179(5):1695-9. (PMID: 8163946)
Lab Invest. 1984 Jun;50(6):690-702. (PMID: 6727301)
J Exp Med. 2007 Feb 19;204(2):239-43. (PMID: 17296790)
J Immunol. 1991 Dec 1;147(11):3815-22. (PMID: 1940369)
Ann Rheum Dis. 2015 Nov;74(11):2084-91. (PMID: 25028707)
Gene Ther. 2011 Jul;18(7):719-26. (PMID: 21390071)
Annu Rev Physiol. 2014;76:467-92. (PMID: 24313723)
Biorheology. 2008;45(3-4):433-8. (PMID: 18836243)
Arch Histol Cytol. 2000 Mar;63(1):17-31. (PMID: 10770586)
Arthritis Rheum. 1988 Mar;31(3):315-24. (PMID: 3358796)
Clin Exp Rheumatol. 2003 Nov-Dec;21(6):753-8. (PMID: 14740455)
Br J Rheumatol. 1998 Jun;37(6):636-42. (PMID: 9667617)
J Med Chem. 2015 Jan 22;58(2):537-59. (PMID: 25365541)
Br J Pharmacol. 2014 Sep;171(17):4087-96. (PMID: 24824742)
Arthritis Res Ther. 2009;11(3):R83. (PMID: 19497113)
N Engl J Med. 2011 Dec 8;365(23):2205-19. (PMID: 22150039)
Arthritis Rheum. 1991 Sep;34(9):1125-32. (PMID: 1930331)
Cardiovasc Res. 2006 Feb 1;69(2):412-22. (PMID: 16376326)

0 (IL10 protein, human)
0 (Interleukin-1beta)
0 (RNA, Messenger)
0 (Tumor Necrosis Factor-alpha)
130068-27-8 (Interleukin-10)
EC 1.13.11.34 (Arachidonate 5-Lipoxygenase)
EC 1.3.11.34 (ALOX5 protein, human)

Date Created: 20170321 Date Completed: 20170710 Latest Revision: 20220311

20250114

PMC5337844

10.1155/2017/9243736

28316377